Suad Efendic

Use of glp-1 analogs and derivatives administered peripherally in regulation of obesity

Use of GLP-1 or analogs in treatment of myocardial infarction

Use of GLP-1 or analogs to abolish catabolic changes after surgery

Use of glp-1 or analogs in treatment of stroke

Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery

Use of GLP-1 and analogs administered peripherally, in regulation of obesity

Verwendung von glp-1 oder analoge in der behandlung von myokardischem infarkt

Verwendung von glukagon-ähnlichem peptid-1 (glp-1) oder dessen analoge zur unterdrückung von postoperativen katabolischen veränderungen

Periphäre verabreichung von glp-1 analogen und derivate zur reguleirung der fettleibigkeit

Use of analogs and derivatives of GLP-1 administered peripherally for the regulation of obesity.